Omission of Axillary Lymph Node Dissection in Patients with Residual Nodal Disease After Neoadjuvant Chemotherapy
Authors:
Top Cited Papers
- 4 September 2024
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (13) , 8813-8820
Abstract
Axillary management after neoadjuvant chemotherapy (NAC) is evolving but axillary lymph node dissection (ALND) remains the standard of care for patients wiKeywords
This publication has 21 references indexed in Scilit:
- Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant ChemotherapyJAMA Oncology, 2024
- Omission of Axillary Dissection in Node Positive Breast Cancer After Neoadjuvant Systemic TherapyJournal of Surgical Research, 2023
- Omission of axillary lymph node dissection in patients with ypN+ breast cancer after neoadjuvant chemotherapy: A retrospective multicenter study (KROG 21-06)European Journal of Surgical Oncology, 2022
- Implications of missing data on reported breast cancer mortalityBreast Cancer Research and Treatment, 2022
- Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy—A Rare EventJAMA Oncology, 2021
- Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-studyEuropean Journal of Surgical Oncology, 2021
- Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?Breast Cancer Research and Treatment, 2019
- Axillary Nodal Management Following Neoadjuvant ChemotherapyJAMA Oncology, 2017
- Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast CancerJAMA, 2013
- Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trialThe Lancet Oncology, 2007